3239 |
SURTAVI: Step-by-Step Moving Forward to Low Risk and Younger Patients |
Eberhard Grube |
Apr. 25. 17 |
3238 |
Lotus |
Hyo-Soo Kim |
Apr. 25. 17 |
3237 |
Evolut R |
Eberhard Grube |
Apr. 25. 17 |
3236 |
Sapien 3 |
Kentaro Hayashida |
Apr. 25. 17 |
3235 |
Percutaneous Mitral/Tricuspid Repair; State-of-the Art and Future Directions |
Ted Feldman |
Apr. 25. 17 |
3234 |
Current and Future Landscape of Trans-Catheter Mitral Valve Replacement |
Maurice Buchbinder |
Apr. 25. 17 |
3233 |
Bioprosthetic Valve Thrombosis(TAVR & SAVR) |
David R. Holmes |
Apr. 25. 17 |
3232 |
LAA Occlusion for Stroke Prevention: What Is the Ideal? |
David R. Holmes |
Apr. 25. 17 |
3231 |
What Is the Optimal Duration of DAPT After PCI/DES? |
David Joel Cohen |
Apr. 25. 17 |
3230 |
Laser Lithotripsy: A Promising Technique for Treatment of Stenosed Under Deployed Stents |
James R. Margolis |
Apr. 25. 17 |